Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

AP-003-C Study to Confirm the Efficacy of Ampion™ in Adults With Pain Due to Severe Osteoarthritis of the Knee

ClinicalTrials.gov ID: NCT03182686

Public ClinicalTrials.gov record NCT03182686. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 2, 2026, 3:44 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3 Randomized Study to Confirm the Efficacy of an Intra-Articular Injection of Ampion™ in Adults With Pain Due to Severe Osteoarthritis of the Knee

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a phase 3 randomized study to confirm the efficacy of an intra-articular injection of Ampion™ in adults with pain due to severe osteoarthritis of the knee.

Study identification

NCT ID
NCT03182686
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Ampio Pharmaceuticals. Inc.
Industry
Enrollment
168 participants

Conditions and interventions

Eligibility (public fields only)

Age range
40 Years to 85 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 18, 2017
Primary completion
Dec 6, 2017
Completion
Dec 6, 2017
Last update posted
Aug 8, 2022

2017

United States locations

U.S. sites
13
U.S. states
10
U.S. cities
13
Facility City State ZIP Site status
Central Research Associates, Inc. Birmingham Alabama 35205
CORE Orthopaedic Medical Center Encinitas California 92024
St. Joseph Heritage Fullerton California 92835
Artemis Institute for Clinical Research San Diego California 92103
Westlake Medical Research Thousand Oaks California 91360
Drug Studies America Marietta Georgia 30060
Healthcare Research Netword Blue Island Illinois 60406
Heartland Research Associates Wichita Kansas 67207
Arthritis Treatment Center Frederick Maryland 21702
Healthcare Network Research Hazelwood Missouri 63042
Coastal Carolina Center at Lowcountry Orthopaedics North Charleston South Carolina 29406
Tekton Research Austin Texas 78745
Northwest Clinical Research Center Bellevue Washington 98007

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03182686, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 8, 2022 · Synced Sep 2, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03182686 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →